Literature DB >> 7902050

Elevated concentrations of circulating ICAM-1 in far advanced and miliary tuberculosis.

N Shijubo1, K Imai, F Nakanishi, A Yachi, S Abe.   

Abstract

Intercellular adhesion molecule-1 (ICAM-1) plays an important role in inflammatory diseases. Cellular expression and shedding of ICAM-1 are up-regulated by cytokines, such as tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma). With an ELISA containing two monoclonal antibodies to human ICAM-1, we measured concentrations of circulating ICAM-1 in patients with tuberculosis. Prominently elevated values were found in miliary tuberculosis and in far advanced pulmonary tuberculosis but not in minimal or moderately advanced disease. The measurement of serum IFN-gamma and TNF-alpha also revealed high concentrations of the cytokines in miliary tuberculosis and far advanced pulmonary tuberculosis. The circulating ICAM-1 values were significantly correlated to serum IFN-gamma and TNF-alpha values. In the case of miliary tuberculosis and far advanced pulmonary tuberculosis treated with antituberculous drugs, the circulating ICAM-1 concentrations were gradually decreased to correspond with improvement of clinical symptoms and chest X-ray findings. The measurement of circulating ICAM-1 is useful to evaluate the severity of tuberculosis and to monitor disease activity during antituberculous drug treatment.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7902050     DOI: 10.1164/ajrccm/148.5.1298

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  7 in total

1.  Soluble intercellular adhesion molecule-1 (ICAM-1) in sera and bronchoalveolar lavage (BAL) fluids of extrinsic allergic alveolitis.

Authors:  N Shijubo; K Imai; K Shigehara; M Hirasawa; M Tsujisaki; Y Hinoda; S Abe
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

2.  Immunohistochemical evidence for loss of ICAM-1 by alveolar epithelial cells in pulmonary fibrosis.

Authors:  M Kasper; R Koslowski; T Luther; D Schuh; M Müller; K W Wenzel
Journal:  Histochem Cell Biol       Date:  1995-11       Impact factor: 4.304

3.  Serum biomarkers of treatment response within a randomized clinical trial for pulmonary tuberculosis.

Authors:  A Jayakumar; E Vittinghoff; M R Segal; W R MacKenzie; J L Johnson; P Gitta; J Saukkonen; J Anderson; M Weiner; M Engle; C Yoon; M Kato-Maeda; P Nahid
Journal:  Tuberculosis (Edinb)       Date:  2015-05-09       Impact factor: 3.131

4.  Tuberculosis (TB) and HIV infection are independently associated with elevated serum concentrations of tumour necrosis factor receptor type 1 and beta2-microglobulin, respectively.

Authors:  S D Lawn; D Rudolph; S Wiktor; D Coulibaly; A Ackah; R B Lal
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

5.  Altered expression of CD11/CD18 on the peripheral blood phagocytes of patients with tuberculosis.

Authors:  R J Yassin; A S Hamblin
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

6.  Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin in patients with tuberculous pleuritis.

Authors:  A Hamzaoui; K Hamzaoui; A Kahan; A Chabbou
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

7.  Activation of protein kinase C by mycobacterial cord factor, trehalose 6-monomycolate, resulting in tumor necrosis factor-alpha release in mouse lung tissues.

Authors:  E Sueoka; S Nishiwaki; S Okabe; N Iida; M Suganuma; I Yano; K Aoki; H Fujiki
Journal:  Jpn J Cancer Res       Date:  1995-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.